MRA Advisory Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$741K Buy
+6,713
New +$648K 0.28% 57
2026
Q2
– Sell
-7,843
Closed -$507K – 166
2026
Q1
$507K Buy
7,843
+448
+6% +$31.6K 0.21% 69
2025
Q4
$498K Sell
7,395
-1,228
-14% -$82.6K 0.21% 65
2025
Q3
$632K Sell
8,623
-98
-1% -$6.51K 0.28% 56
2025
Q2
$454K Buy
+8,721
New +$496K 0.21% 73

Other funds holding HALO

MRA Advisory Group's HALO Position: Q3 2026 in Review

MRA Advisory Group opened a new position in Halozyme (HALO) in Q3 2026: 6,713 shares worth $741K. The stake represents 0.28% of the portfolio and ranks #57 among its holdings. This is a return to the name: MRA Advisory Group previously reported a position in HALO as recently as Q1 2026.

MRA Advisory Group first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 188 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • MRA Advisory Group held 6,713 shares of Halozyme worth $741K as of Q3 2026.
  • Halozyme was a new MRA Advisory Group position in Q3 2026.
  • Halozyme made up 0.28% of MRA Advisory Group's portfolio in Q3 2026, its #57 holding.
  • MRA Advisory Group first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
  • 188 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on MRA Advisory Group's 13F filing for Q3 2026, filed 7 Oct 2026.